Choline and fructooligosaccharide: Non-alcoholic fatty liver disease, cardiac fat deposition, and oxidative stress markers

Nutrition and Metabolic Insights

Volumn 8, Issue , 2015, Pages 1-6

  Haubert, Nadia Juliana Beraldo Goulart Borges ^a   Marchini, Julio Sergio ^a   Cunha, Selma Freire Carvalho ^a   Suen, Vivian Marques Miguel ^a   Padovan, Gilberto Joao ^a   Jordao, Alceu Afonso ^a   Alves, Claudia Maria Meirelles Marchini ^a   Marchini, Julio Flavio Meirelles ^a   Vannucchi, Helio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Choline; Fructooligosaccharide; Heart fat; Liver fat; Tic steatosis

Indexed keywords

EID: 85030657168     PISSN: None     EISSN: 11786388     Source Type: Journal    
DOI: 10.4137/NMI.S24385     Document Type: Article

References (47)

1. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis. 1986;8:283-298.
2. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12:1106-1110.
3. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979;67:811-816.
4. Liangpunsakul S, Chalasani N. What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol. 2012;107:976-978.
5. Bugianesi E, Marzocchi R, Villanova N, Marchesini G. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract Res Clin Gastroenterol. 2004;18:1105-1116.
6. Tailleux A, Wouters K, Staels B. Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta. 2012;1821:809-818.
7. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem. 2005;38:203-217.
8. Malaguarnera M, Vacante M, Antic T, et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci. 2012;57:545-553.
9. Pachikian BD, Essaghir A, Demoulin JB, et al. Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways. Mol Nutr Food Res. 2013;57:347-359.
10. Busserolles J, Gueux E, Rock E, Demigne C, Mazur A, Rayssiguier Y. Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr. 2003;133:1903-1908.
11. Wang H, Khaoustov VI, Krishnan B, et al. Total parenteral nutrition induces liver steatosis and apoptosis in neonatal piglets. J Nutr. 2006;136:2547-2552.
12. Yasutake K, Kohjima M, Nakashima M, Kotoh K, Nakamuta M, Enjoji M. Nutrition therapy for liver diseases based on the status of nutritional intake. Gastroenterol Res Pract. 2012;2012:859697.
13. Oliveira CP, Coelho AM, Barbeiro HV, et al. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res. 2006;39:189-194.
14. Nakamura S, Kondo N, Yamaguchi Y, et al. Daily feeding of fructooligosaccharide or glucomannan delays onset of senescence in SAMP8 mice. Gastroenterol Res Pract. 2014;2014:303184.
15. Schugar RC, Huang X, Moll AR, Brunt EM, Crawford PA. Role of choline deficiency in the fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet. PLoS One. 2013;8:e74806.
16. Duric M, Sivanesan S, Bakovic M. Phosphatidylcholine functional foods and nutraceuticals: a potential approach to prevent non-alcoholic fatty liver disease. Eur J Lipid Sci Technol. 2012;114:389-398.
17. Costa GT, Guimaraes SB, Sampaio HA. Fructo-oligosaccharide effects on blood glucose: an overview. Acta Cir Bras. 2012;27:279-282.
18. Moshfegh AJ, Friday JE, Goldman JP, Ahuja JK. Presence of inulin and oligofructose in the diets of Americans. J Nutr. 1999;129:1407S-1411S.
19. Yu D, Shu XO, Xiang YB, et al. Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. J Nutr. 2014;144:2034-2040.
20. Guerrerio AL, Colvin RM, Schwartz AK, et al. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012;95:892-900.
21. Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol. 2013;19:6911-6918.
22. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci. 2007;52:3259-3265.
23. Cassani RSL, Cunha SFC, Freitas ALG, Nonino CB, Marchini JS. Effects of nutritional counseling on the anthropometric and biochemical nutritional data of obese workers: a randomized blind study. Univ J Clin Med. 2013;1:6-12.
24. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-1951.
25. Haubert NJ, Padovan GJ, Zucoloto S, Vannucchi H, Marchini JS. Experimental induction of steatosis in different tissues after the ingestion of a carbohydrate-rich diet: effect on the liver, on the heart and on indicators of oxidation. Arq Gastroenterol. 2010;47:388-392.
26. Lieber CS, Leo MA, Mak KM, et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 2004;79:502-509.
27. Mendler MH, Kanel G, Govindarajan S. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease. Liver Int. 2005;25:294-304.
28. Skogerboe KJ, Labbe RF, Rettmer RL, Sundquist JP, Gargett AM. Chemiluminescent measurement of total urinary nitrogen for accurate calculation of nitrogen balance. Clin Chem. 1990;36:752-755.
29. Conway EJ. Apparatus for the micro-determination of certain volatile substances: the blood ammonia, with observations on normal human blood. Biochem J. 1935;29:2755-2772.
30. Marchini JS, Lambertini CR, Ferriolli E, Dutra de Oliveira JE. Obese women on a low energy rice and bean diet: effects of leucine, arginine or glycine supplementation on protein turnover. Braz J Med Biol Res. 2001;34:1277-1283.
31. AOAC International. AOAC Official Methods of Analysis of AOAC International. Washington, DC, USA: AOAC; 1995.
32. Feldsine P, Abeyta C, Andrews WH; Committee AIM. AOAC International methods committee guidelines for validation of qualitative and quantitative food microbiological official methods of analysis. J AOAC Int. 2002;85:1187-1200.
33. Svingen BA, Buege JA, O'Neal FO, Aust SD. The mechanism of NADPH-dependent lipid peroxidation. The propagation of lipid peroxidation. J Biol Chem. 1979;254:5892-5899.
34. Gueguen S, Pirollet P, Leroy P, et al. Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation. J Am Coll Nutr. 2003;22:303-310.
35. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192-205.
36. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7:251-264.
37. Bacon BR, Park CH, Fowell EM, McLaren CE. Hepatic steatosis in rats fed diets with varying concentrations of sucrose. Fundam Appl Toxicol. 1984;4:819-826.
38. Axen KV, Axen K. Very low-carbohydrate versus isocaloric high-carbohydrate diet in dietary obese rats. Obesity. 2006;14:1344-1352.
39. Delzenne NM, Kok N. Effects of fructans-type prebiotics on lipid metabolism. Am J Clin Nutr. 2001;73:456S-458S.
40. Al Rajabi A, Castro GS, da Silva RP, et al. Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. J Nutr. 2014;144:252-257.
41. Ozarda Y, Cansev M, Ulus IH. Breast milk choline contents are associated with inflammatory status of breastfeeding women. J Hum Lact. 2014;30:161-166.
42. Grattagliano I, Vendemiale G, Caraceni P, et al. Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet. J Nutr. 2000;130:2131-2136.
43. Kashireddy PR, Rao MS. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med. 2004;229:158-162.
44. Hongu N, Sachan DS. Caffeine, carnitine and choline supplementation of rats decreases body fat and serum leptin concentration as does exercise. J Nutr. 2000;130:152-157.
45. Al-Saeedi FJ, Cheng B. Choline treatment affects the liver reticuloendothelial system and plasma fatty acid composition in diabetic rats. Clin Physiol Funct Imaging. 2013;33:293-301.
46. Passos LML, Park YK. [Fructooligosaccharides: implactions in human health and use in food.]. Cienc Rural. 2003;33:385-390.
47. Sun ZH, Tan ZL, Liu SM, et al. Effects of dietary methionine and lysine sources on nutrient digestion, nitrogen utilization, and duodenal amino acid flow in growing goats. J Anim Sci. 2007;85:3340-3347.